FLT3-Mediated p38–MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis-Reference-Cited by-同舟云学术

FLT3-Mediated p38–MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis

Published:2011-04-12 Issue:8 Volume:71 Page:2901-2915
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Desterke Christophe,Bilhou-Nabéra Chrystele,Guerton Bernadette,Martinaud Christophe,Tonetti Carole,Clay Denis,Guglielmelli Paola,Vannucchi Alessandro,Bordessoule Dominique,Hasselbalch Hans,Dupriez Brigitte,Benzoubir Nassima,Bourgeade Marie-Françoise,Pierre-Louis Olivier,Lazar Vladimir,Vainchenker William,Bennaceur-Griscelli Annelise,Gisslinger Heinz,Giraudier Stéphane,Le Bousse-Kerdilès Marie-Caroline

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation;iScience;2024-09

2. A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis;Clinical Cancer Research;2023-07-13

3. Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?;Cancers;2023-02-20

4. Protein arginine methyltransferase 1 in the generation of immune megakaryocytes: A perspective review;Journal of Biological Chemistry;2022-11

5. Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases;European Journal of Medicinal Chemistry;2022-09